retatrutide phase 2 trial obesity triple agonist First-in-Class 'Triple-G'! Retatrutide, a first-in Retatrutide FDA Approval Status 2026:
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19


























